Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy

This study has been completed.
Pharma Nord
Information provided by:
Oslo University Hospital Identifier:
First received: June 8, 2005
Last updated: June 30, 2011
Last verified: September 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2007
  Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)